Seven Tips for Healthcare & Life Sciences Companies Engaging Independent Monitors and Compliance Experts - Life Sciences Perspectives Seven Tips ...
DEA Announces Temporary Extension of COVID-19 Telehealth Flexibilities for Prescription of Controlled Medications - Life Sciences Perspectives DEA Announces Temporary ...
Clinical trial diversity is not a new concept–the U.S. Food and Drug Administration (FDA) issued a draft guidance providing specific ...
The Long (Un)Winding Road: FDA Maps Out How the End of the Public Health Emergency Will Impact its COVID-19 Policies ...
The 340B Drug Pricing Program is a government program, administered by the Health Resources and Services Administration (HRSA), that allows ...
The legislation previously introduced as the Pre-Approval Information Exchange Act of 2022 (“PIE Act”) was passed as part of Congress’s December 23, ...
On September 28, 2022, the U.S. Food and Drug Administration (“FDA” or “the Agency”) issued its long-awaited final guidance, “Clinical ...
FDA Announces Total Product Life Cycle Advisory Program (TAP) Pilot - Life Sciences Perspectives FDA Announces Total Product Life Cycle ...
Five Key Regulatory Considerations for Virtual Ketamine Clinics - Life Sciences Perspectives Five Key Regulatory Considerations for Virtual Ketamine Clinics ...
On July 28, 2022, the U.S. Food and Drug Administration (FDA) will hold a public advisory committee meeting to discuss ...
After sunlight completes its eight-minute journey to Earth, white surfaces such as clouds send much of it bouncing right back...
Read moreLast summer, in various cities in the UK, more than 40,000 people visited the Dreamachine, a large space designed to...
Read moreGlaciers in the Arctic are not nearly as devoid of life as they might appear at first sight.In fact, carpets...
Read moreThe Study Monitor/CRA conduct monitoring visits for assigned trial protocol and trial sites. Overall responsibilities are to ensure that the...
Read more
© Life Sciences News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.
